Fortis Healthcare reported an 82% YoY rise in Q2 profit to ₹322 crore, driven by strong operational performance and improved margins.
1 Min Read
Fortis Healthcare Ltd reported a robust set of numbers for the September quarter, with consolidated net profit soaring 82% year-on-year to ₹322 crore, compared to ₹176.5 crore in the same period last year.
Revenue grew 17.3% to ₹2,331.4 crore, supported by sustained growth across its hospital and diagnostics businesses.
Operating performance remained healthy, with EBITDA rising 28% year-on-year to ₹557 crore, while margins expanded to 24% from 22% a year ago, reflecting improved cost management and higher occupancy levels across key facilities.
Ahead of the earnings announcement, shares of Fortis Healthcare closed at ₹983.90, down 0.89% on the NSE.
Also Read: PTC India Q2 Results: Profit dips 12% despite double-digit revenue and EBITDA growth
Separately, IHH Healthcare Berhad announced the completion of its mandatory open offers for both Fortis Healthcare Ltd and Fortis Malar Hospitals Ltd, marking a key milestone in its strategic expansion in India’s healthcare sector.
Also Read: Malaysia’s IHH launches open offer for 26.1% stake in Fortis Healthcare
Continue Reading